【レポートの概要（一部）】
Table of Content
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
Chapter 3. Market Snapshot
Chapter 4. Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Driver Analysis
4.3. Market Restraint Analysis
4.4. Penetration & Growth Prospect Mapping
4.5. SWOT Analysis, By Factor
4.5.1. Political
4.5.2. Economic
4.5.3. Technological
4.6. Industry Analysis – Porter’s
4.7. Competitive Landscape & Market Share Analysis, 2015 & 2030
4.8. Liquid Biopsy Pipeline Analysis, 2015 – 2020
Chapter 5. Market Categorization 1: Application Estimates & Trend Analysis
5.1. Application Movement Analysis & Market Share, 2015, 2020 & 2030
5.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following applications:
5.2.1. Therapy Selection for Metastatic Breast Cancer (MBS)
5.2.2. Therapy Selection for Other Metastatic Cancer
5.2.3. Molecular Health Monitoring
Chapter 6. Market Categorization 2: Sample Type Estimates & Trend Analysis
6.1. Sample Type Movement Analysis & Market Share, 2015, 2020 & 2030
6.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following sample types:
6.2.1. Blood Samples
6.2.2. Urine Samples
6.2.3. Other Bio fluids (Tissue fluids and Saliva)
Chapter 7. Market Categorization 3: Biomarker Estimates & Trend Analysis
7.1. Biomarker Movement Analysis & Market Share, 2015, 2020 & 2030
7.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following biomarkers:
7.2.1. Circulating Tumor Cells (CTC)
7.2.2. Circulating Tumor DNA (ctDNA)
7.2.3. Exosomes (Macrovesicles with Protein, RNA, DNA)
Chapter 8. Market Categorization 4: Technology Estimates & Trend Analysis
8.1. Technology Movement Analysis & Market Share, 2015, 2020 & 2030
8.2. Market Size & Forecasts and Trend Analyses, 2013 to 2030 for the following technologies:
8.2.1. Multi-gene parallel Analysis using NGS
8.2.2. Single Gene Analysis using PCR Microarrays
Chapter 9. Market Categorization 3: Regional Estimates & Trend Analysis
9.1. Regional Movement Analysis & Market Share, 2015, 2020 & 2030
9.2. North America
9.2.1. North America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.2.1.1. U.S.
9.2.1.2. Canada
9.2.2. North America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.2.2.1. U.S.
9.2.2.2. Canada
9.2.3. North America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.2.3.1. U.S.
9.2.3.2. Canada
9.2.4. North America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.2.4.1. U.S.
9.2.4.2. Canada
9.3. Europe
9.3.1. Europe revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.3.1.1. Germany
9.3.1.2. UK
9.3.2. Europe revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.3.2.1. Germany
9.3.2.2. UK
9.3.3. Europe revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.3.3.1. Germany
9.3.3.2. UK
9.3.4. Europe revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.3.4.1. Germany
9.3.4.2. UK
9.4. Asia Pacific
9.4.1. Asia Pacific revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.4.1.1. Japan
9.4.1.2. China
9.4.2. Asia Pacific revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.4.2.1. Japan
9.4.2.2. China
9.4.3. Asia Pacific revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.4.3.1. Japan
9.4.3.2. China
9.4.4. Asia Pacific revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.4.4.1. Japan
9.4.4.2. China
9.5. Latin America
9.5.1. Latin America revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.5.1.1. Brazil
9.5.2. Latin America revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.5.2.1. Brazil
9.5.3. Latin America revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.5.3.1. Brazil
9.5.4. Latin America revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.5.4.1. Brazil
9.6. Middle East & Africa
9.6.1. Middle East & Africa revenue estimates and forecasts by application, 2013 – 2030 (USD Million)
9.6.1.1. South Africa
9.6.2. Middle East & Africa revenue estimates and forecasts by sample type, 2013 – 2030 (USD Million)
9.6.2.1. South Africa
9.6.3. Middle East & Africa revenue estimates and forecasts by biomarker, 2013 – 2030 (USD Million)
9.6.3.1. South Africa
9.6.4. Middle East & Africa revenue estimates and forecasts by technology, 2013 – 2030 (USD Million)
9.6.4.1. South Africa
Chapter 10. Competitive Landscape
10.1. Adaptive Biotechnologies
10.1.1. Company Overview
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives
10.2. Biocept
10.2.1. Company Overview
10.2.2. Financial Performance
10.2.3. Product Benchmarking
10.2.4. Strategic Initiatives
10.3. Guardant Health
10.3.1. Company Overview
10.3.2. Financial Performance
10.3.3. Product Benchmarking
10.3.4. Strategic Initiatives
10.4. NeoGenomics Laboratories
10.4.1. Company Overview
10.4.2. Financial Performance
10.4.3. Product Benchmarking
10.4.4. Strategic Initiatives
10.5. Personal Genome Diagnostics
10.5.1. Company Overview
10.5.2. Financial Performance
10.5.3. Product Benchmarking
10.5.4. Strategic Initiatives
10.6. Qiagen
10.6.1. Company Overview
10.6.2. Financial Performance
10.6.3. Product Benchmarking
10.6.4. Strategic Initiatives
10.7. RainDance Technologies
10.7.1. Company Overview
10.7.2. Financial Performance
10.7.3. Product Benchmarking
10.7.4. Strategic Initiatives
10.8. Trovagene
10.8.1. Company Overview
10.8.2. Financial Performance
10.8.3. Product Benchmarking
10.8.4. Strategic Initiatives
10.9. Cynvenio
10.9.1. Company Overview
10.9.2. Financial Performance
10.9.3. Product Benchmarking
10.9.4. Strategic Initiatives
10.10. Epic Sciences
10.10.1. Company Overview
10.10.2. Financial Performance
10.10.3. Product Benchmarking
10.10.4. Strategic Initiatives
10.11. Exosome
10.11.1. Company Overview
10.11.2. Financial Performance
10.11.3. Product Benchmarking
10.11.4. Strategic Initiatives
10.12. Foundation Medicine
10.12.1. Company Overview
10.12.2. Financial Performance
10.12.3. Product Benchmarking
10.12.4. Strategic Initiatives
10.13. Genomic Health
10.13.1. Company Overview
10.13.2. Financial Performance
10.13.3. Product Benchmarking
10.13.4. Strategic Initiatives
10.14. Illumina Inc.
10.14.1. Company Overview
10.14.2. Financial Performance
10.14.4. Strategic Initiatives
10.15. Angle Plc
10.15.1. Company Overview
10.15.2. Financial Performance
10.15.3. Product Benchmarking
10.15.4. Strategic Initiatives
10.16. Boreal Genomics
10.16.1. Company Overview
10.16.2. Financial Performance
10.16.3. Product Benchmarking
10.16.4. Strategic Initiatives
10.17. CareDx
10.17.1. Company Overview
10.17.2. Financial Performance
10.17.3. Product Benchmarking
10.17.4. Strategic Initiatives
10.18. Chronix Biomedical
10.18.1. Company Overview
10.18.2. Financial Performance
10.18.3. Product Benchmarking
10.18.4. Strategic Initiatives
10.19. Cynvenio Biosystems Inc.
10.19.1. Company Overview
10.19.2. Financial Performance
10.19.3. Product Benchmarking
10.19.4. Strategic Initiatives
10.20. Epic Sciences
10.20.1. Company Overview
10.20.2. Financial Performance
10.20.3. Product Benchmarking
10.20.4. Strategic Initiatives
10.21. Foundation Medicine
10.21.1. Company Overview
10.21.2. Financial Performance
10.21.3. Product Benchmarking
10.21.4. Strategic Initiatives
10.22. Natera Inc.
10.22.1. Company Overview
10.22.2. Financial Performance
10.22.3. Product Benchmarking
10.22.4. Strategic Initiatives
10.23. Pathway Genomics
10.23.1. Company Overview
10.23.2. Financial Performance
10.23.3. Product Benchmarking
10.23.4. Strategic Initiatives
10.24. Roche (Ariosa)
10.24.1. Company Overview
10.24.2. Financial Performance
10.24.3. Product Benchmarking
10.24.4. Strategic Initiatives
10.25. Sequenom
10.25.1. Company Overview
10.25.2. Financial Performance
10.25.3. Product Benchmarking
10.25.4. Strategic Initiatives
10.26. Trovagene
10.26.1. Company Overview
10.26.2. Financial Performance
10.26.3. Product Benchmarking
10.26.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：液体生検の世界市場分析：用途別（転移性乳がん（MBS）の治療選択、他の転移性がんの治療選択、分子モニタリング、分子モニタリング）、サンプル別（血液、尿、組織および唾液）、バイオマーカー別（循環腫瘍細胞（CTC）、循環腫瘍DNA（ctDNA）、エキソソーム）、技術別（単一遺伝子解析（PCRマイクロアレイ）、多遺伝子並列分析（NGS））、動向分析、2013-2030■ 英文：Liquid Biopsy Market Size & Forecast By Application (Therapy Selection for Metastatic Breast Cancer (MBS), Therapy Selection for Other Metastatic Cancers, Molecular Monitoring, Molecular Monitoring), By Sample Type (Blood, Urine, Tissue & Saliva), By Biomarker Type (Circulating Tumor Cells (CTC), Circulating Tumor DNA (ctDNA), Exosomes), By Technology (Single Gene Analysis (PCR Microarrays), Multi-gene-parallel Analysis (NGS)) And Trend Analysis from 2013 To 2030
■ 発行日：2016年9月8日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707486
■ 調査対象地域：グローバル
- モジュールチラーの世界市場予測（～2024年）“The modular chillers market is projected to register a CAGR of 6.0% between 2019 and 2024.”The modular chillers market is estimated to be USD 2.6 billion in 2019 and is projected to reach USD 3.5 billion by 2024, at a CAGR of 6.0%. This growth is attributed to the advantages and benefits of modular chillers over its substitutes. Also, the demand for modular chillers is driven by growth in the num …
- 幹細胞治療の世界市場2017-2021About stem cell therapyStem cell therapy is the use of stem cells for the treatment or prevention of a disease or condition. Bone marrow transplant is the widely-used stem cell therapy, followed by therapies derived from umbilical cord blood. Research is being undertaken to develop various sources (such as cord blood cells, bone marrow, and skin) for stem cells, and to apply them to various disord …
- 世界のホスト型アプリケーション管理サービス市場About Hosted Application Management Services A hosted application, also known as internet-based application or web-based application, is an online application where the application software resides on servers and can be accessed through the internet. Hosted applications are among the pioneer service models of cloud services, allowing end-users to receive a similar application functionality experie …
- 免疫治療薬の世界市場：モノクローナル抗体、免疫チェックポイント阻害薬、ワクチン、非特異的免疫療法About Immunotherapy Drugs Immunotherapy enhances the innate powers of the immune system. The properties of the immune system to fight abnormal cells give immunotherapy drugs the chance of successfully fighting diseases such as cancer, respiratory, infectious, and autoimmune disorders. Technavio’s analysts forecast the global immunotherapy drugs market to grow at a CAGR of 11.52% during the period …
- 指揮・統制システムの世界市場：プラットフォーム別（陸上、海上、宇宙、空中）、ソリューション別、アプリケーション別（防衛、商業）、セグメント予測The global command and control systems market size is anticipated to reach USD 25.04 billion by 2025, registering a CAGR of 3.8% over the forecast period, according to a new report by Grand View Research, Inc. Increasing military budgets of Asian countries, such as China and India, rising influence of terror groups in Iraq, Syria, and Palestine, and technological advancements in defense industry a …
- 高等教育モバイルラーニングの世界市場2015-2019About M-Learning Products and Services M-learning provides education-related content on smartphones and tablets. Education-related content refers to all the digital learning content available on personal devices. M-learning service providers deliver learning solutions through latest tools and technology, which impart users with rich media and graphics-based learning. This method of learning is cos …
- 世界のFTTx通信市場：国別加入者、事業者データn/a
- 世界の木質ペレット市場2015Global Wood-Pellets Industry Report 2015 is a professional and in-depth study on the current state of the Wood-Pellets industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Wood-Pellets market analysis is provided for the China markets including development trends, competitive landscape analysis, and ke …
- ホーム・エネルギー管理システム（HEMS）の世界市場：制御デバイス、ディスプレイ、通信デバイスThe global Home Energy Management System Market is expected to grow from USD 864.2 Million in 2015 to USD 3.15 Billion by 2022, at a CAGR of 18.36% between 2016 and 2022. The HEMS market is expected to grow substantially owing to factors such as increasing real-time energy conservation approach, convenience of cloud computing and data analytics, and increased device interconnectivity. Lighting con …
- 腫瘍向けコンパニオン診断：グローバル市場分析と予測MediPoint: Companion Diagnostic Tests in Oncology - Global Analysis and Market Forecasts Summary A companion diagnostic test is defined as an in vitro diagnostic device or an imaging tool whose use allows the safe application of a therapy. In-vitro Companion Diagnostic tests measure the expression or presence of a specific biomarker that is linked to a disease condition or therapy. This report pro …
- 男性不妊の世界市場2017-2021About Male InfertilityMale infertility is a widespread disorder, which refers to a male's inability to impregnate his fertile female partner. It occurs due to deficiencies in semen, poor sperm quality, lower hormonal support, and abnormal ejaculation. Technavio’s analysts forecast the global male infertility market to grow at a CAGR of 5.68% during the period 2017-2021. [Covered in this report] Th …
- 電子走査アレイの世界市場予測：アクティブ電子走査アレイ（AESA）、パッシブ電子走査アレイ（PESA）The electronically scanned arrays market is projected to grow from USD 6.24 Billion in 2016 to USD 8.43 Billion by 2021, at a CAGR of 6.20% during the forecast period. Replacement of traditional electronically scanned array systems and integration of active electronically scanned arrays with traditional radar system components are key factors expected to drive the growth of the electronically scan …
- 世界の風力発電システムO&M（運用・保守）サービス市場About Wind Energy O&M O&M is crucial in any wind energy system and is still quite capital intensive. This is because the use of wind energy does not require fuel expenses; therefore, the expenditure for the equipment represents the main component cost. An adequate O&M is necessary to protect the equipment to keep them running during their expected lifetime. Good O&M practices can optimize the prof …
- 食品サービスの世界市場予測・分析2020-2024Global Foodservice Market: About this market Technavio’s foodservice market analysis considers sales from conventional, centralized, ready-prepared, and assembly-serve foodservice systems. Our study also finds the sales of foodservice in APAC, Europe, MEA, North America, and South America. In 2019, the conventional segment had a significant market share, and this trend is expected to continue over …
- ロイヤリティ管理の世界市場予測（～2021）：ソリューション種類別（顧客ロイヤリティ、人材定着、チャネルロイヤリティ）、導入種類別、企業規模別、産業別、地域別The loyalty management market is projected to grow from USD 1.68 Billion in 2016 to USD 4.59 Billion by 2021, at a CAGR of 22.2% during the forecast period, 2016 to 2021. Major drivers for the growth of the market include rising need for competitive differentiation among organizations to increase their market shares, frequent shift in consumer demographics, increasing focus of loyalty programs on …
